Viewing Study NCT01786135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-02-18 @ 2:55 PM
Study NCT ID: NCT01786135
Status: COMPLETED
Last Update Posted: 2017-10-19
First Post: 2013-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety Study of SGN-CD19A for B-Cell Lymphoma
Sponsor: Seagen Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Burkitt Lymphoma View
None Lymphoma, Follicular View
None Lymphoma, Large B-Cell, Diffuse View
None Lymphoma, Mantle-Cell View
None Precursor B-cell Lymphoblastic Leukemia-Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antibodies, Monoclonal View
None Antibody-Drug Conjugate View
None Antigens, CD19 View
None B-Lineage Lymphoblastic Lymphoma View
None Burkitt Lymphoma View
None Diffuse Large B-Cell Lymphoma View
None Mantle Cell Lymphoma View
None B-Cell Lymphoma View
None Drug Therapy View
None Monomethylauristatin F View
None Follicular Lymphoma Grade 3 View